Tariquidar
 |
| ATC code |
|
N-[2-[[4-[2-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide
|
| CAS Number |
|
|
PubChem CID
|
|
| ChemSpider |
|
| UNII |
|
| ChEMBL |
|
|
CompTox Dashboard (EPA)
|
|
| Formula |
C38H38N4O6
|
| Molar mass |
646.744 g·mol−1
|
| 3D model (JSmol) |
|
COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)NC(=O)C4=CC(=C(C=C4NC(=O)C5=CC6=CC=CC=C6N=C5)OC)OC)OC
|
InChI=1S/C38H38N4O6/c1-45-33-18-25-14-16-42(23-28(25)19-34(33)46-2)15-13-24-9-11-29(12-10-24)40-38(44)30-20-35(47-3)36(48-4)21-32(30)41-37(43)27-17-26-7-5-6-8-31(26)39-22-27/h5-12,17-22H,13-16,23H2,1-4H3,(H,40,44)(H,41,43) N
Key:LGGHDPFKSSRQNS-UHFFFAOYSA-N N
|
N Y (what is this?) (verify)
|
Tariquidar (INN/USAN) is a P-glycoprotein inhibitor undergoing research as an adjuvant against multidrug resistance in cancer.